Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
3.270
+0.060 (1.87%)
Nov 5, 2024, 3:43 PM EST - Market open
Phio Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 4.7 | 8.49 | 11.78 | 24.06 | 14.24 | 6.93 | Upgrade
|
| Cash & Short-Term Investments | 4.7 | 8.49 | 11.78 | 24.06 | 14.24 | 6.93 | Upgrade
|
| Cash Growth | -58.45% | -27.93% | -51.03% | 68.89% | 105.42% | -53.40% | Upgrade
|
| Prepaid Expenses | 0.59 | 0.83 | 0.62 | 0.62 | 0.87 | 0.32 | Upgrade
|
| Restricted Cash | - | - | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Total Current Assets | 5.29 | 9.32 | 12.45 | 24.73 | 15.16 | 7.3 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.04 | 0.34 | 0.42 | 0.56 | 0.72 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0.02 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Total Assets | 5.3 | 9.36 | 12.81 | 25.17 | 15.74 | 8.04 | Upgrade
|
| Accounts Payable | 0.34 | 0.66 | 0.78 | 0.28 | 0.73 | 0.81 | Upgrade
|
| Accrued Expenses | 1.19 | 0.87 | 1.01 | 2.66 | 1.25 | 0.94 | Upgrade
|
| Current Portion of Leases | - | 0.04 | 0.14 | 0.13 | 0.12 | 0.11 | Upgrade
|
| Other Current Liabilities | - | 0.08 | 0.02 | - | 0.1 | 0.03 | Upgrade
|
| Total Current Liabilities | 1.52 | 1.63 | 1.94 | 3.07 | 2.2 | 1.88 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.23 | - | Upgrade
|
| Long-Term Leases | - | - | 0.04 | 0.17 | 0.3 | 0.41 | Upgrade
|
| Total Liabilities | 1.52 | 1.63 | 1.97 | 3.24 | 2.72 | 2.29 | Upgrade
|
| Common Stock | - | - | - | - | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 146.98 | 146.94 | 139.22 | 138.83 | 116.63 | 100.57 | Upgrade
|
| Retained Earnings | -143.21 | -139.21 | -128.38 | -116.9 | -103.61 | -94.82 | Upgrade
|
| Total Common Equity | 3.77 | 7.73 | 10.84 | 21.93 | 13.02 | 5.75 | Upgrade
|
| Shareholders' Equity | 3.77 | 7.73 | 10.84 | 21.93 | 13.02 | 5.75 | Upgrade
|
| Total Liabilities & Equity | 5.3 | 9.36 | 12.81 | 25.17 | 15.74 | 8.04 | Upgrade
|
| Total Debt | - | 0.04 | 0.17 | 0.3 | 0.64 | 0.52 | Upgrade
|
| Net Cash (Debt) | 4.7 | 8.46 | 11.61 | 23.76 | 13.6 | 6.42 | Upgrade
|
| Net Cash Growth | -58.06% | -27.18% | -51.14% | 74.69% | 112.00% | -56.88% | Upgrade
|
| Net Cash Per Share | 11.56 | 36.52 | 91.94 | 200.01 | 320.24 | - | Upgrade
|
| Filing Date Shares Outstanding | 0.86 | 0.51 | 0.13 | 0.13 | 0.13 | 0.03 | Upgrade
|
| Total Common Shares Outstanding | 0.51 | 0.42 | 0.13 | 0.13 | 0.05 | - | Upgrade
|
| Working Capital | 3.77 | 7.69 | 10.51 | 21.66 | 12.97 | 5.42 | Upgrade
|
| Book Value Per Share | 7.40 | 18.57 | 85.64 | 175.00 | 243.18 | - | Upgrade
|
| Tangible Book Value | 3.77 | 7.73 | 10.84 | 21.93 | 13.02 | 5.75 | Upgrade
|
| Tangible Book Value Per Share | 7.40 | 18.57 | 85.64 | 175.00 | 243.18 | - | Upgrade
|
| Machinery | - | 1.1 | 1.31 | 1.19 | 1.23 | - | Upgrade
|
| Leasehold Improvements | - | 0.05 | 0.05 | 0.05 | 0.05 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.